Published ahead of print on December 3, 2004, doi:10.1164/rccm.200404-558OC
American Journal of Respiratory and Critical Care Medicine Vol 171. pp. 838-843, (2005)
© 2005 American Thoracic Society
doi: 10.1164/rccm.200404-558OC
Lipid Peroxidation and 5-Lipoxygenase Activity in Chronic Obstructive Pulmonary Disease
Pierachille Santus,
Alessandra Sola,
Paolo Carlucci,
Francesca Fumagalli,
Antonio Di Gennaro,
Michele Mondoni,
Chiara Carnini,
Stefano Centanni and
Angelo Sala
Institute of Respiratory Medicine, Ospedale S. Paolo; and Department of Pharmacological Sciences, Center for Cardiopulmonary Pharmacology, University of Milan, Milan, Italy
Correspondence and requests for reprints should be addressed to Angelo Sala, Ph.D., Department of Pharmacological Sciences, Center for Cardiopulmonary Pharmacology, Via Balzaretti 9, Milan 20133, Italy. E-mail: angelo.sala{at}unimi.it
We studied the urinary excretion of the isoprostane 8-iso-prostaglandin F2 as an index of in vivo oxidant stress, and the production of leukotriene (LT) B4 (LTB4) by neutrophils in subjects with chronic obstructive pulmonary disease (COPD) and normal subjects. Overnight urinary excretion of the isoprostane was significantly higher in patients with COPD than in control subjects, and LTB4 production by challenge of neutrophils obtained from patients with COPD was also significantly higher than that observed in control neutrophils. Treatment with a standardized polyphenol extract caused a significant decrease in isoprostane excretion, accompanied by a statistically significant increase of PaO2. Furthermore, changes in FEV1 significantly correlated with the changes in isoprostane urinary excretion observed from enrollment to the end of treatment. The results of this study suggest that enhanced oxidative stress in subjects with COPD is paralleled by the increased ability of neutrophils to synthesize the chemotactic factor LTB4, and may ultimately contribute to the infiltration/activation of neutrophils into the airways of subjects with COPD. Antioxidant treatment in subjects with COPD is effective in reducing oxidant stress as shown by the decrease of urinary isoprostane, a reduction that correlates with the severity of the disease, as indicated by changes in PaO2 and FEV1.
Key Words: leukotriene B4 natural polyphenols neutrophils oxidative stress urinary isoprostanes
This article has been cited by other articles:

|
 |

|
 |
 
I. Rahman
Review: Antioxidant therapeutic advances in COPD
Therapeutic Advances in Respiratory Disease,
December 1, 2008;
2(6):
351 - 374.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Szulakowski, A. J. L. Crowther, L. A. Jimenez, K. Donaldson, R. Mayer, T. B. Leonard, W. MacNee, and E. M. Drost
The Effect of Smoking on the Transcriptional Regulation of Lung Inflammation in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
July 1, 2006;
174(1):
41 - 50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe
Update in chronic obstructive pulmonary disease 2005.
Am. J. Respir. Crit. Care Med.,
May 15, 2006;
173(10):
1056 - 1065.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Juul, A. Tybjaerg-Hansen, S. Marklund, P. Lange, and B. G. Nordestgaard
Genetically Increased Antioxidative Protection and Decreased Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
April 15, 2006;
173(8):
858 - 864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. F. Foronjy, O. Mirochnitchenko, O. Propokenko, V. Lemaitre, Y. Jia, M. Inouye, Y. Okada, and J. M. D'Armiento
Superoxide Dismutase Expression Attenuates Cigarette Smoke- or Elastase-generated Emphysema in Mice
Am. J. Respir. Crit. Care Med.,
March 15, 2006;
173(6):
623 - 631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yasuda, M. Yamaya, K. Nakayama, S. Ebihara, T. Sasaki, S. Okinaga, D. Inoue, M. Asada, M. Nemoto, and H. Sasaki
Increased Arterial Carboxyhemoglobin Concentrations in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
June 1, 2005;
171(11):
1246 - 1251.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 American Thoracic Society
|
|
|